Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama.
George Washington University Biostatistics Center, Washington, Dist. of Columbia.
Am J Perinatol. 2024 Jan;41(2):160-166. doi: 10.1055/a-1675-0901. Epub 2021 Oct 20.
The fetal consequences of intrapartum fetal tachycardia with maternal fever or clinical chorioamnionitis are not well studied. We evaluated the association between perinatal morbidity and fetal tachycardia in the setting of intrapartum fever.
Secondary analysis of a multicenter randomized control trial that enrolled 5,341 healthy laboring nulliparous women ≥36 weeks' gestation. Women with intrapartum fever ≥ 38.0°C (including those meeting criteria for clinical chorioamnionitis) after randomization were included in this analysis. Isolated fetal tachycardia was defined as fetal heart rate (FHR) ≥160 beats per minute for at least 10 minutes in the absence of other FHR abnormalities. FHR abnormalities other than tachycardia were excluded from the analysis. The primary outcome was a perinatal composite (5-minute Apgar's score ≤3, intubation, chest compressions, or mortality). Secondary outcomes included low arterial cord pH (pH < 7.20), base deficit ≥12, and cesarean delivery.
A total of 986 (18.5%) of women in the trial developed intrapartum fever, and 728 (13.7%) met criteria to be analyzed; of these, 728 women 336 (46.2%) had maternal-fetal medicine (MFM) reviewer-defined fetal tachycardia, and 349 of the 550 (63.5%) women during the final hour of labor had validated software (PeriCALM) defined fetal tachycardia. After adjusting for confounders, isolated fetal tachycardia was not associated with a significant difference in the composite perinatal outcome (adjusted odds ratio [aOR] = 3.15 [0.82-12.03]) compared with absence of tachycardia. Fetal tachycardia was associated with higher odds of arterial cord pH <7.2, aOR = 1.48 (1.01-2.17) and of infants with a base deficit ≥ 12, aOR = 2.42 (1.02-5.77), but no significant difference in the odds of cesarean delivery, aOR = 1.33 (0.97-1.82).
Fetal tachycardia in the setting of intrapartum fever or chorioamnionitis is associated with significantly increased fetal acidemia defined as a pH <7.2 and base excess ≥12 but not with a composite perinatal morbidity.
· The perinatal outcomes associated with fetal tachycardia in the setting of maternal fever are undefined.. · Fetal tachycardia was not significantly associated with perinatal morbidity although the sample size was limited.. · Fetal tachycardia was associated with an arterial cord pH <7.2 and base deficit of 12 or greater..
分娩期胎儿心动过速伴母体发热或临床绒毛膜羊膜炎对胎儿的影响尚未得到充分研究。我们评估了分娩期发热时胎儿心动过速与围产儿发病率之间的关系。
这是一项多中心随机对照试验的二次分析,纳入了 5341 例≥36 孕周的健康初产妇。随机分组后出现发热≥38.0°C(包括符合临床绒毛膜羊膜炎标准的患者)的孕妇纳入本分析。孤立性胎儿心动过速定义为胎儿心率(FHR)≥160 次/分钟,持续至少 10 分钟,无其他 FHR 异常。分析中排除了除心动过速以外的 FHR 异常。主要结局为围产儿复合结局(5 分钟 Apgar 评分≤3 分、气管插管、胸外按压或死亡)。次要结局包括脐动脉 pH 值<7.20、碱缺失≥12 和剖宫产。
试验中共有 986 例(18.5%)孕妇出现分娩期发热,其中 728 例(13.7%)符合分析标准;其中,728 例孕妇中有 336 例(46.2%)有母体胎儿医学(MFM)审查者定义的胎儿心动过速,550 例孕妇中有 349 例(63.5%)在分娩最后 1 小时有经软件(PeriCALM)验证的胎儿心动过速。调整混杂因素后,与无心动过速相比,孤立性胎儿心动过速与围产儿复合结局无显著差异(调整优势比[aOR] = 3.15[0.82-12.03])。胎儿心动过速与脐动脉 pH 值<7.2 的风险增加相关,aOR=1.48(1.01-2.17),与碱缺失≥12 的风险增加相关,aOR=2.42(1.02-5.77),但与剖宫产的风险无显著差异,aOR=1.33(0.97-1.82)。
分娩期发热或绒毛膜羊膜炎时胎儿心动过速与胎儿酸中毒(定义为 pH 值<7.2 和碱缺失≥12)显著相关,但与围产儿发病率无显著相关性。
· 母体发热时胎儿心动过速相关的围产儿结局尚不清楚。· 尽管样本量有限,但胎儿心动过速与围产儿发病率无显著相关性。· 胎儿心动过速与脐动脉 pH 值<7.2 和碱缺失≥12 相关。